USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...
Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...
Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market (B3) and a regional leader in hospital pharmaceuticals with a strong presence across Latin America, announces an ...
VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis Therapeutics (“DTx”), a preclinical-stage biotechnology company developing gene therapies for ophthalmic diseases, has entered into a strategic ...
China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...
The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...
Scheduled for August 2025 completion, the initial $2-billion phase included construction of a 1-million-sq-ft complex with two drug substance manufacturing buildings, each containing four 20,000-liter ...
When the FDA unexpectedly uploaded around 200 drug rejection letters this week, the regulator provided an in-depth view into the high-stakes discussions that decide whether a medicine will ever make ...
Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 MonthsAccelerated pathway: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback